Evidence map›Paper›PMID 38687077›Full record

ArticleMicrobiology spectrum2024

Identification of novel resistance-associated mutations and discrimination within whole-genome sequences of fluoroquinolone-resistant

Yingzhi Chong, Xueying Li, Yifei Long, Shengfei Pei, Qi Ren, Fumin Feng, Haibo Zhang

Abstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yingzhi ChongHebei Coordinated Innovation Center of Occupational Health and Safety, School of Public Health, North China University of Science and Technology, Tangshan, Hebei Province, China.ORCID 0000-0002-1335-839X
Xueying LiHebei Coordinated Innovation Center of Occupational Health and Safety, School of Public Health, North China University of Science and Technology, Tangshan, Hebei Province, China.
Yifei LongHebei Coordinated Innovation Center of Occupational Health and Safety, School of Public Health, North China University of Science and Technology, Tangshan, Hebei Province, China.
Shengfei PeiHebei Coordinated Innovation Center of Occupational Health and Safety, School of Public Health, North China University of Science and Technology, Tangshan, Hebei Province, China.
Qi Ren *Hebei Coordinated Innovation Center of Occupational Health and Safety, School of Public Health, North China University of Science and Technology, Tangshan, Hebei Province, China.ORCID 0009-0006-1734-7520
Fumin Feng *Hebei Coordinated Innovation Center of Occupational Health and Safety, School of Public Health, North China University of Science and Technology, Tangshan, Hebei Province, China.ORCID 0000-0001-6506-2235
Haibo ZhangHebei Coordinated Innovation Center of Occupational Health and Safety, School of Public Health, North China University of Science and Technology, Tangshan, Hebei Province, China.

Funding

| Hebei Province Graduate Innovation Funding Project () CXZZBS2023122| Natural Science Foundation of Hebei Province () H2022209018
6 · The paper itself

Abstract

This study aims to elucidate additional mutation loci associated with fluoroquinolone (FQ) resistance and evaluate the discriminatory capacity of mutation loci and allele mutation frequencies in identifying FQ-resistant

Indexed as

Antitubercular AgentsFluoroquinolonesMicrobial Sensitivity TestsMutationMycobacterium tuberculosisTuberculosis, Multidrug-ResistantWhole Genome SequencingDNA GyraseDrug Resistance, BacterialGenome, BacterialHumansAntitubercular AgentsDNA GyraseFluoroquinolonesfluoroquinoloneMycobacterium tuberculosisresistancetuberculosiswhole-genome sequencing

Identifiers

PMID38687077
PMCPMC11237524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.